Literature DB >> 31655112

Antibiotic use among hospitalized adult patients in a setting with limited laboratory infrastructure in Freetown Sierra Leone, 2017-2018.

Sulaiman Lakoh1, Olukemi Adekanmbi2, Darlinda F Jiba3, Gibrilla F Deen4, Wadzani Gashau3, Stephen Sevalie5, Eili Y Klein6.   

Abstract

OBJECTIVES: Our study aimed to assess antibiotic use in adult inpatients in the context of limited laboratory services at the main tertiary hospital in Sierra Leone.
DESIGN: A cross-sectional study of consecutive adult inpatients (≥18 years) between October 2017 and February 2018 at Connaught Hospital in Freetown.
RESULTS: A total of 920 patients were interviewed, of which 753 (81.8%) had at least one antibiotic. Complete data was captured for 688 (91.0%) patients. The median age was 41 years and 52.8% were male. Fever was reported in 41.5% of patients, though 85.1% had no leukocyte count prior to antibiotic use and none had a bacterial culture. Indications for prescribing were surgical prophylaxis (15.7%), pneumonia (15.1%), and trauma (5.8%). Cephalosporins (25.9%), penicillins (23.2%), and imidazoles (20.8%) were commonly prescribed.
CONCLUSION: We found high rates of antibiotic use, of which most was not based on laboratory evidence. Lack of oversight and microbiological support are drivers of poor prescribing in many developing countries, which lack financial resources and serve a sicker population. Greater investments are needed to establish antimicrobial stewardship programs and provide clinicians with diagnostic support to enable improvements in patient outcomes and curb the spread of antibiotic resistance.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Antimicrobial stewardship; Laboratory

Mesh:

Substances:

Year:  2019        PMID: 31655112     DOI: 10.1016/j.ijid.2019.10.022

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Infection Prevention and Control in Three Tertiary Healthcare Facilities in Freetown, Sierra Leone during the COVID-19 Pandemic: More Needs to Be Done!

Authors:  Ibrahim Franklyn Kamara; Sia Morenike Tengbe; Bobson Derrick Fofanah; James Edward Bunn; Charles Kuria Njuguna; Christiana Kallon; Ajay M V Kumar
Journal:  Int J Environ Res Public Health       Date:  2022-04-26       Impact factor: 4.614

2.  Debunking highly prevalent health misinformation using audio dramas delivered by WhatsApp: evidence from a randomised controlled trial in Sierra Leone.

Authors:  Maike Winters; Ben Oppenheim; Paul Sengeh; Mohammad B Jalloh; Nance Webber; Samuel Abu Pratt; Bailah Leigh; Helle Molsted-Alvesson; Zangin Zeebari; Carl Johan Sundberg; Mohamed F Jalloh; Helena Nordenstedt
Journal:  BMJ Glob Health       Date:  2021-11

3.  Incidence and risk factors of surgical site infections and related antibiotic resistance in Freetown, Sierra Leone: a prospective cohort study.

Authors:  Sulaiman Lakoh; Le Yi; Stephen Sevalie; Xuejun Guo; Olukemi Adekanmbi; Isaac O Smalle; Nathaniel Williams; Umu Barrie; Celesis Koroma; Yongkun Zhao; Matilda N Kamara; Constance Cummings-John; Darlinda F Jiba; Enanga Sonia Namanaga; Betsy Deen; Juling Zhang; Anna Maruta; Christiana Kallon; Peng Liu; Haja Ramatulai Wurie; Joseph Sam Kanu; Gibrilla F Deen; Mohamed Samai; Foday Sahr; Emmanuel Firima
Journal:  Antimicrob Resist Infect Control       Date:  2022-02-21       Impact factor: 4.887

4.  First Report of the Colistin Resistance Gene mcr-10.1 Carried by IncpA1763-KPC Plasmid pSL12517-mcr10.1 in Enterobacter cloacae in Sierra Leone.

Authors:  Jiayao Guan; Letian Li; Lin Zheng; Gejin Lu; Ying Wang; Sulaiman Lakoh; Stephen Sevalie; Bowen Jiang; Xue Ji; Yang Sun; Jun Liu; Lingwei Zhu; Xuejun Guo
Journal:  Microbiol Spectr       Date:  2022-06-13

5.  Antibiotic resistance in patients with clinical features of healthcare-associated infections in an urban tertiary hospital in Sierra Leone: a cross-sectional study.

Authors:  Sulaiman Lakoh; Letian Li; Stephen Sevalie; Xuejun Guo; Olukemi Adekanmbi; Guang Yang; Oladimeji Adebayo; Le Yi; Joshua M Coker; Shuchao Wang; Tiecheng Wang; Weiyang Sun; Abdulrazaq G Habib; Eili Y Klein
Journal:  Antimicrob Resist Infect Control       Date:  2020-02-22       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.